Stability Testing for Lyophilized Biologics
Many biologics—such as monoclonal antibodies, peptides, vaccines, and enzymes—are inherently unstable in liquid form. Lyophilization provides the following benefits:
Click to read the full article.
Stability Testing Types
Comparative Analysis: Freeze-Thaw vs. Accelerated Stability Testing
Available from Pharma SOP:
Click to read the full article.
Regulatory Expectations for Stability Testing of Biosimilars
Biosimilars are highly similar but not identical to innovator biologics. As such, they must demonstrate:
Click to read the full article.
Impact of Freeze-Thaw on Microbial Limits in Sterile Products
Available from Pharma SOP:
Click to read the full article.
Freeze-Thaw Stress During Product Distribution: Detection and Documentation
Available from Pharma SOP:
Click to read the full article.
Stress Testing Strategies for Biopharmaceuticals
Stress testing serves several key objectives in product development and regulatory compliance:
Click to read the full article.
Cold Chain Risk Assessment in Global Drug Supply
Available from Pharma SOP:
Click to read the full article.
Freeze-Thaw Stability Evaluation of Biologics
Biologic products—especially proteins and monoclonal antibodies—are sensitive to temperature fluctuations. Freezing and thawing can induce:
Click to read the full article.
Implementing ICH Q1A in Freeze-Thaw Study Design
Available from Pharma SOP:
Click to read the full article.
Photostability Testing of Biopharmaceutical Products
Biopharmaceuticals such as monoclonal antibodies, peptides, and protein-based vaccines contain amino acids like tryptophan, tyrosine, and phenylalanine, which absorb UV light and are prone to photodegradation. Exposure to light can cause:
Click to read the full article.